These are the findings of a comprehensive study into sustainable ways of preventing patients from being harmed as a result of prescribing errors.
The research was led by Tony Avery, Professor of Primary Health Care in the School of Community Health Sciences at The University of Nottingham and funded by the Patient Safety Research Program of the UK Department of Health. The results are published on Tuesday 21 February 2012 in the Lancet - one of the world's leading medical journals.
The study involved at-risk patients in 72 general practices taking the drugs that are most commonly and consistently associated with medication errors.
The general practices were randomly allocated to receive either computerised feedback on patients at risk, or computerised feedback with support from a pharmacist to correct any errors detected. When followed up six months later the general practices receiving pharmacist support had significantly fewer prescribing errors.
Professor Avery, who is also a practicing GP in Nottingham, has called on the Department of Health and GP clinical commissioning groups to develop a wider roll-out of the intervention scheme. He said: "Our study has shown remarkable reductions in prescribing errors from an approach that could easily be rolled out to general practices in England and the rest of the UK. Most general practices already have in-house pharmacists, but much of their time is spent controlling prescribing costs. What is needed is a commitment for these pharmacists to spend more of their time on patient safety. Not only would this help prevent unnecessary harm to patients, but it may also reduce the costs associated with dealing with prescribing errors, which sometimes require hospital admission".How the study was set up
Practices allocated to the simple feedback system received computerised feedback on patients at risk from medication errors and the practices were given brief written information on the importance of each type of error.
GPs allocated to pharmacist-intervention met with a pharmacist at the beginning of intervention period to discuss the problems identified from the computerised feedback and to agree on an action plan. The pharmacist then spent roughly two days a week for the next 12 weeks dealing with the problems and working to improve safety systems. In some cases, patients were invited into the surgery for a prescription review with the pharmacist, or a GP, or to have a blood test, with the aim of correcting medication errors.The results of the study
Professor Avery said: "We know that GPs are aware of the risks of the drugs most commonly associated with adverse events, but errors do occur and our study has shown an effective way of dealing with them. We believe that there is an urgent need to roll out this pharmacist-led intervention to general practices throughout the country to avoid unnecessary errors in the future."
Lindsay Brooke | EurekAlert!
Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State
NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Physics and Astronomy
08.12.2016 | Health and Medicine
08.12.2016 | Life Sciences